Women's Health & Hormonal Medicines in India | Kasdap Healthcare

Women's Health in India: Progress and Persistent Gaps

India's women's health landscape has undergone significant transformation over the past two decades. Maternal mortality rates have fallen substantially, contraceptive prevalence has increased, and awareness of conditions like PCOS, endometriosis, and osteoporosis has grown meaningfully in urban populations.

Yet significant challenges remain. Anaemia affects over 50% of Indian women of reproductive age. PCOS is estimated to affect 1 in 5 women. Cervical cancer remains a major cause of female cancer mortality. Menopause-related conditions are vastly under-diagnosed and undertreated. Closing these gaps requires consistent access to quality, affordable women's health medicines across India's diverse healthcare infrastructure.

Hormonal Contraception: Options and Considerations

Combined Oral Contraceptives (COCs)

Combined oral contraceptives containing oestrogen and progestogen remain one of the most widely used reversible contraceptive methods globally and in India. Modern low-dose COCs (containing 20–35 mcg Ethinylestradiol) have significantly improved the safety profile compared to earlier higher-dose formulations, while maintaining excellent contraceptive efficacy when taken correctly.

Beyond contraception, COCs are widely prescribed for managing dysmenorrhea, premenstrual syndrome (PMS), PCOS-related menstrual irregularities, and acne. Patient selection requires careful assessment of cardiovascular risk factors, smoking status, and contraindications to oestrogen.

Progestin-Only Pills (Mini-Pills)

Progestin-only pills containing Norethindrone or Desogestrel are the preferred oral contraceptive option for breastfeeding women, those with contraindications to oestrogen, and smokers over 35. They require stricter timing adherence than COCs for maximum efficacy.

Emergency Contraception

Levonorgestrel 1.5mg (Plan B) is the most widely available emergency contraceptive in India, effective when taken within 72 hours of unprotected intercourse. Ulipristal acetate offers a 120-hour window. Emergency contraception prevents pregnancy primarily by delaying or inhibiting ovulation — it is not an abortifacient.

PCOS: India's Most Common Endocrine Disorder in Women

Polycystic Ovarian Syndrome (PCOS) affects an estimated 1 in 5 Indian women of reproductive age, making it one of the most prevalent endocrine conditions in the country. Management is multifaceted, targeting the various manifestations of the syndrome:

• Metformin: First-line pharmacological treatment for metabolic manifestations of PCOS, improving insulin sensitivity and menstrual regularity
• Combined Oral Contraceptives: Used for menstrual regulation and management of hyperandrogenic features (acne, hirsutism)
• Clomiphene Citrate: First-line ovulation induction agent for PCOS-related infertility
• Letrozole: Aromatase inhibitor increasingly preferred over Clomiphene for ovulation induction due to superior live birth rates
• Anti-androgens (Spironolactone, Cyproterone acetate): Used for hirsutism and acne in PCOS when COCs alone are insufficient

Fertility and Reproductive Health

India's assisted reproductive technology (ART) sector is one of the fastest-growing in the world. Pharmacological support for fertility treatment encompasses:

• Gonadotrophins (FSH, LH, hCG): For controlled ovarian stimulation in IVF/ICSI cycles
• GnRH analogues (agonists and antagonists): Used to prevent premature LH surges during ovarian stimulation
• Progesterone supplementation: Essential for luteal phase support post-embryo transfer
• Thyroid hormones: Hypothyroidism is a common, treatable cause of infertility and recurrent pregnancy loss

Menopause Management

Approximately 50 million Indian women are postmenopausal, yet menopause-related conditions remain vastly underdiagnosed and undertreated due to stigma, limited awareness, and physician hesitancy regarding HRT.

Hormone Replacement Therapy (HRT)

Modern HRT uses the lowest effective hormone doses for the shortest duration needed to manage symptoms. Oestrogen-only HRT is used in women without a uterus; combined oestrogen-progestogen HRT is required for women with an intact uterus to protect the endometrium. Non-oral routes (transdermal patches, gels) offer improved cardiovascular safety compared to oral oestrogen.

Non-Hormonal Alternatives

For women with contraindications to HRT or those preferring non-hormonal options, alternatives include SSRIs/SNRIs for vasomotor symptoms, Clonidine for hot flushes, and Ospemifene (a SERM) for genitourinary syndrome of menopause.

Iron, Folate, and Nutritional Support in Women's Health

Iron deficiency anaemia is the most prevalent nutritional deficiency among Indian women. The National Iron Plus Initiative recommends iron-folic acid supplementation for adolescent girls, pregnant women, and lactating mothers. Key formulations include:

• Ferrous Sulphate: Most affordable oral iron; GI side effects common
• Iron Polymaltose Complex (IPC): Better GI tolerability, no interaction with food; preferred in children and pregnant women
• Ferric Carboxymaltose (IV): For severe anaemia or oral iron intolerance
• Folic Acid: Critical pre-conception and in first trimester for neural tube defect prevention

Kasdap Healthcare's Women's & Hormonal Portfolio

Kasdap Healthcare's Women's & Hormonal segment provides a comprehensive range including hormonal contraceptives, fertility medicines, menopause management, and women's nutritional supplements — all manufactured under WHO-GMP aligned standards and distributed through our pan-India network.